Vertaling van "Cognitive behaviour therapy " (Engels → Nederlands) :

cognitive behaviour therapy | cognitive-behavioural therapy | cognitive behavioural therapy | cognitive-behavioural therapies

apply cognitive behaviour treatment techniques | use cognitive behaviour treatment techniques | employ cognitive behaviour treatment techniques | use cognitive behaviour treatment

characteristics of behavioural therapy | foundations of behavioural therapy | behavioural therapy | methods in behavioural therapy

Guided self-help cognitive behavioral therapy

behaviour therapy | BT [Abbr.]

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical ...[+++]signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

A rare epilepsy syndrome characterised by late-onset (after 1 year old) epileptic spasms that occur in clusters, associated with tonic seizures, atypical absences and cognitive deterioration. Language difficulties and behaviour problems are frequentl

Beck cognitive therapy

21. Recognises the current importance of the European Union's support, totalling EUR 159 million, for 34 projects on neurodegenerative diseases; considers it essential, nevertheless, in the context of the forthcoming 8th RDFP, to address the fragmented nature of research, particularly that on Alzheimer's, and to include projects in the insufficiently explored fields of non-drug, behavioural and cognitive therapies;

21. Recognises the current importance of the European Union's support, totalling EUR 159 million, for 34 projects on neurodegenerative diseases; considers it essential, nevertheless, in the context of the forthcoming 8th RDFP, to address the fragmented nature of research, particularly that on Alzheimer's, and to include projects in the insufficiently explored fields of non-drug, behavioural and cognitive therapies;

21. Recognises the current importance of the European Union’s support, totalling EUR 159 million, for 34 projects on neurodegenerative diseases; considers it essential, nevertheless, in the context of the forthcoming 8th RDFP, to address the fragmented nature of research, particularly that on Alzheimer’s, and to include projects in the insufficiently explored fields of non-drug, behavioural and cognitive therapies;

The EU gives a considerable amount of money – EUR 159 million – to 34 neurodegenerative disease research programmes, but since there will be a huge increase in these diseases, research projects under the Eighth Framework Programme must be broadened to include research on behavioural, cognitive and non-drug therapies.